Disintegrin and metalloproteinase domain-containing protein 33

BE0019245ProteinHumansADAM33

Metalloprotease that cleaves and sheds the ectodomains of cell-surface proteins and thereby contributes to angiogenesis, cell differentiation, inflammation, and cell proliferation (PubMed:14676211, PubMed:33982767). It is acted on by 1 drug in DrugBank.

Gene name
ADAM33
UniProtKB entry
Q9BZ11Swiss-Prot
Cellular location
Cell membrane
Residues / weight
813 residues · 87,738 Da
Also known as
3.4.24.- · ADAM 33 · C20orf153

Resolves to

Drugs

What you can answer from here — as of September 03, 2024

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
5GO termsFunction, process and component, as structured annotations
Sign in
4Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Disintegrin and metalloproteinase domain-containing protein 33, and which indications are they being tested in?

Create a free account or log in to explore the full data card.

Create Account